睾丸非精原生殖细胞瘤化疗后转移性成熟畸胎瘤与生长性畸胎瘤综合征
本文综述睾丸非精原生殖细胞瘤患者化疗后转移性成熟畸胎瘤的临床、病理及多模态影像特征。成熟畸胎瘤因对化疗耐药而残留,可进展为生长性畸胎瘤综合征,即血清肿瘤标志物正常下残存肿块增大。CT是化疗后监测首选影像方法,应覆盖所有潜在转移部位。
要点
- 化疗后残留肿块需考虑成熟畸胎瘤,CT监测应覆盖全部潜在转移部位。
- 血清肿瘤标志物正常而残存肿块增大提示生长性畸胎瘤综合征。
- 成熟畸胎瘤有恶性潜能并可侵犯周围结构,应手术切除。
核心结论
- 转移性成熟畸胎瘤是转移性非精原生殖细胞瘤化疗后常见的影像与病理表现,应手术切除。
研究设计与样本
- 本文为综述,总结睾丸原发非精原生殖细胞瘤患者转移性成熟畸胎瘤的临床、病理及多模态影像特征。
关键影像表现/征象
- 化疗后残存肿块病理为成熟畸胎瘤,影像上表现为残存肿块。
- 生长性畸胎瘤综合征表现为血清肿瘤标志物正常背景下残存肿块增大。
诊断标准与关键数值
- 生长性畸胎瘤综合征定义为血清肿瘤标志物正常时残存肿块增大且组织学证实为成熟畸胎瘤。
临床应用与阅片要点
- CT是化疗后监测首选影像方法,扫描范围应覆盖所有潜在转移部位。
- 发现残存肿块增大而肿瘤标志物正常时,应提示生长性畸胎瘤综合征可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Metastatic mature teratoma is a common radiologic and histopathologic finding after chemotherapy for metastatic non-seminomatous germ cell tumors. The leading theory for these residual tumors is the selective chemotherapy resistance of teratomas versus the high chemotherapy sensitivity of the embryonal components. Growing teratoma syndrome is a relatively rare phenomenon defined as an enlarging residual mass histologically proven to be a mature teratoma in the setting of normal serum tumor markers. Metastatic mature teratomas should be resected because of their malignant potential and occasional progression to growing teratoma syndrome with the invasion of the surrounding structures. CT is the preferred imaging modality for post-chemotherapy surveillance and should cover all sites of potential metastatic disease. This article reviews the clinical, pathologic, and multimodality imaging features of metastatic mature teratomas in patients with primary testicular non-seminomatous germ cell tumors.
引用
- Green DB, La Rosa FG, Craig PG, et al. Metastatic Mature Teratoma and Growing Teratoma Syndrome in Patients with Testicular Non-Seminomatous Germ Cell Tumors. Korean J Radiol. 2021. PMID: 34402242. doi:10.3348/kjr.2020.1391
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。